An in vivo systematic genetic analysis of tumour progression in Drosophila - RNAi line: 4153R-2

Metastasis is the leading cause of death for cancer patients. Consequently it is imperative that we improve our understanding of the molecular mechanisms that underlie progression of tumour growth towards malignancy. Advances in genome characterisation technologies have been very successful in identifying commonly mutated or misregulated genes in a variety of human cancers. A major challenge however is the translation of these findings to new biological insight due to the difficulty in evaluating whether these candidate genes drive tumour progression. Using the genetic amenability of Drosophila melanogaster we generated tumours with specific genotypes in the living animal and carried out a detailed systematic loss-of-function analysis to identify numerous conserved genes that enhance or suppress epithelial tumour progression. This enabled the discovery of functional cooperative regulators of invasion and the establishment of a network of conserved ‘invasion suppressors’.

RNAi line: 4153R-2 (III)
Source: NIG

Name: eIF-2beta (1)
Full name: eukaryotic translation initiation factor 2 subunit beta
Also known as: eIF2β, eIF-2β, eIF-2, elF2β
Annotation symbol: CG4153
FlyBase ID: FBgn0004926

File naming convention: File names typically contain representations of date (DDMMYY), RNAi Line, Animal Number and, in some cases, window (to accommodate larger samples that require multiple image stacks)

Included files: 050615_lgl_4153R2_An4_combined.tif 201114_An11_4153r2_w_combined.tif 28.10.14_An7_4153r2_w_combined.tif 290515_lgl_4153R2_An2_combined.tif An1 4153R-2.tif